Aminex PLC Notice of EGM (9631M)
January 27 2021 - 2:00AM
UK Regulatory
TIDMAEX
RNS Number : 9631M
Aminex PLC
27 January 2021
27 January 2021
Aminex plc
("Aminex" or "the Company")
Notice of Extraordinary General Meeting
An extraordinary general meeting of the Company will be held at
Kings Buildings, 16 Smith Square, London SW1P 3JJ on 18 February
2021 at 10.00 am (the "EGM").
The business of the EGM will be to consider and, if thought fit,
approve certain resolutions relating to the replacement of CREST
with a system operated by Euroclear Bank SA/NV for the electronic
settlement of trading in the Company's ordinary shares (the
"Migration").
As a result of the withdrawal of the United Kingdom from the
European Union, the CREST settlement system will soon no longer be
able to provide settlement services to Irish incorporated listed
companies. Approval of the resolutions is therefore necessary to
ensure that the Company's shares can continue to be held and
settled electronically when they are traded on the London Stock
Exchange and remain eligible for continued admission to trading and
listing on that exchange, which is crucial to the interests of the
Company and its shareholders as a whole. There is no meaningful
alternative to Migration and failure to migrate would remove the
Company's access to electronic trade settlement.
The circular which includes notice of the EGM (the "Circular")
and a Form of Proxy is being posted to shareholders today. The
Board strongly urges shareholders to review the contents of the
Circular in their entirety, including the documents referred to
therein, and consider the Board's recommendation to vote in favour
of the Resolutions.
The Circular, the Form of Proxy and copies of the documents
referred to in the Circular are available to view on the Company's
website, www.aminex-plc.com and will be available for inspection as
described in the Circular. However, due to Covid-19 public health
guidelines, shareholders are advised to view the documents on the
website.
EGM arrangements and Covid-19
The Company will follow public health guidelines in respect of
social distancing, mass gatherings and other measures taken
regarding Covid-19. The Company will be implementing the relevant
measures advised by UK Government agencies at the EGM in relation
to Covid-19. The wellbeing of our shareholders, staff and others
are our priority. It is the Company's intention to hold the EGM
with the minimum quorum necessary and we strongly advise our
shareholders to submit their forms of proxy by post or
electronically to ensure their vote counts at the EGM given that
personal attendance at the EGM is not recommended under current
Government guidelines. The Company reserves the right to refuse
entry to the meeting where reasonably necessary to comply with the
Covid-19 related public health measures and advice. We would
therefore recommend that you consider appointing the chairperson of
the EGM as your proxy due to the restrictions on other persons
attending the EGM.
The Company will continue to closely monitor the developing
situation around Covid-19, including the latest UK Government
guidance, and how this may affect the arrangements for the EGM.
Consequently, the EGM is subject to change, possibly at short
notice. If it becomes necessary or appropriate to revise the
current arrangements for the EGM, further information will be made
available as quickly as possible by RNS and on our website at
www.aminex-plc.com.
Further information in relation to the EGM
In accordance with the Listing Rules of the Financial Conduct
Authority, copies of the Circular and the Articles of Association
as they are proposed to be amended have been submitted to the UK
National Storage Mechanism and will shortly be available for
inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information:
Aminex PLC +44 20 3198 8415
Robert Ambrose, CEO
Charles Santos, Chairman
Davy +353 1 679 6363
Brian Garrahy
Camarco +44 20 3781 8331
Billy Clegg / James Crothers / Daniel Sherwen
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOGSESFIMEFSEIF
(END) Dow Jones Newswires
January 27, 2021 02:00 ET (07:00 GMT)
Aminex (LSE:AEX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aminex (LSE:AEX)
Historical Stock Chart
From Jul 2023 to Jul 2024